TAE Life Sciences to Develop Groundbreaking Therapy for Difficult-to-Treat Cancers, including Head, Neck and GBM; Announces $40 Million Series A Funding

March 12, 2018

Responsive image

FOOTHILL RANCH, Calif., March 12, 2018 /PRNewswire/ — TAE Life Sciences, a medical technology company developing an accelerator-based platform for clinical investigation of a promising, previously inaccessible cancer treatment, made its public debut today.
TAE Life Sciences has…

Category: Precious Metals